JO
STLNW

John Overdeck’s Starling Oncology Warrant STLNW Stock Holding History

John Overdeck’s Portfolio STLNW Stock Details STLNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-30,000
Closed -$600 – 3489
2024
Q3 		$600 Hold
30,000
– – ﹤0.01% 3082
2024
Q2 		$789 Hold
30,000
– – ﹤0.01% 2987
2024
Q1 		$6K Hold
30,000
– – ﹤0.01% 2967
2023
Q4 		$3.75K Buy
+30,000
New +$4.74K ﹤0.01% 3107

Other funds holding STLNW

LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
AGM
Alpine Global Management New York $615M AUM 34.28% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
TCM
Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return
FL
FreeGulliver LLC New Orleans, Louisiana $284M AUM 24.22% 1-Year Est. Return

John Overdeck's STLNW Position: Q4 2024 in Review

John Overdeck sold out of Starling Oncology Warrant (STLNW) in Q4 2024, closing a stake of 30,000 shares — an estimated $600 sold.

John Overdeck first reported a position in STLNW in Q4 2023 and held it in 4 quarters. The position peaked at $6K in Q1 2024. 14 funds tracked by Wall St. Rank hold STLNW as of Q4 2024.

  • John Overdeck reported no remaining Starling Oncology Warrant position as of Q4 2024 after selling out during the quarter.
  • John Overdeck sold 30,000 Starling Oncology Warrant shares in Q4 2024, an estimated $600.
  • John Overdeck first reported a position in Starling Oncology Warrant in Q4 2023 and held it in 4 quarters.
  • John Overdeck's Starling Oncology Warrant position peaked at $6K in Q1 2024.
  • 14 funds tracked by Wall St. Rank held Starling Oncology Warrant as of Q4 2024.

Based on Two Sigma Investments's 13F filing for Q4 2024, filed 14 Feb 2025.